GenSight Biologics S.A.
SIGHT.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €0 | €2 | €7 | €2 |
| Short-Term Investments | €0 | €0 | €0 | €0 |
| Receivables | €0 | €0 | €0 | €0 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €2 | €3 | €6 | €4 |
| Total Curr. Assets | €3 | €5 | €13 | €7 |
| Property Plant & Equip (Net) | €1 | €1 | €1 | €2 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €0 | €0 | €0 | €0 |
| Long-Term Investments | €4 | €4 | €1 | €1 |
| Tax Assets | €0 | €0 | €0 | €0 |
| Other NC Assets | €0 | €0 | €0 | €0 |
| Total NC Assets | €5 | €5 | €2 | €3 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €7 | €11 | €15 | €9 |
| Liabilities | – | – | – | – |
| Payables | €9 | €6 | €5 | €6 |
| Short-Term Debt | €14 | €14 | €7 | €17 |
| Tax Payable | €0 | €0 | €0 | €0 |
| Deferred Revenue | €0 | €0 | €0 | €2 |
| Other Curr. Liab. | €3 | €2 | €5 | €0 |
| Total Curr. Liab. | €26 | €23 | €17 | €25 |
| LT Debt | €5 | €5 | €16 | €1 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €9 | €10 | €7 | €13 |
| Total NC Liab. | €14 | €15 | €23 | €15 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €1 | €1 | €1 | €2 |
| Total Liabilities | €39 | €38 | €40 | €40 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €197 |
| Common Stock | €3 | €3 | €3 | €2 |
| Retained Earnings | -€7 | -€14 | -€6 | -€26 |
| AOCI | -€236 | -€223 | -€223 | -€197 |
| Other Equity | €208 | €207 | €201 | -€6 |
| Total Equity | -€32 | -€27 | -€25 | -€31 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €7 | €11 | €15 | €9 |
| Net Debt | €19 | €17 | €16 | €16 |